Pharmacist-driven warfarin dose adjustment protocol and its effect on time in therapeutic range: a retrospective cohort analysis

Read full text Summarise with VIRAT
Authors: Ahmed Hassan Saleh, Fatima Yousif Noor
Cited by: 0
References: 18

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Warfarin remains one of the most widely prescribed oral anticoagulants worldwide, yet maintaining patients within the target international normalised ratio (INR) range continues to be a persistent clinical challenge. This research retrospectively examined whether a pharmacist-driven warfarin dose adjustment protocol improved time in therapeutic range (TTR) compared with conventional physician-managed dosing at a tertiary hospital in Khartoum, Sudan. Medical records of 342 adult patients receiving warfarin for atrial fibrillation, deep vein thrombosis, or mechanical heart valve replacement between January 2021 and December 2022 were reviewed. Patients managed under the pharmacist protocol (n = 174) were compared with a historical cohort managed by physicians alone (n = 168). TTR was calculated using the Rosendaal linear interpolation method. At 12 months, the pharmacist-managed group achieved a mean TTR of 72.6%, compared with 54.1% in the physician-managed group (p

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Pharmacy and Medical Practices Pharmaceutical Practices and Patient Outcomes

Publication details

Journal / source
Journal of Pharmacist and Hospital Pharmacy
Volume
3
Issue
1
Pages
15–19
Publication date
1 January 2026
Language
EN